Inhibition by nitrobenzylthioinosine of adenosine uptake by asynchronous HeLa cells. 1977

A R Paterson, and L R Babb, and J H Paran, and C E Cass

UI MeSH Term Description Entries
D007288 Inosine A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
D007700 Kinetics The rate dynamics in chemical or physical systems.
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013868 Thioinosine Sulfhydryl analog of INOSINE that inhibits nucleoside transport across erythrocyte plasma membranes, and has immunosuppressive properties. It has been used similarly to MERCAPTOPURINE in the treatment of leukemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p503) 6-Mercaptopurine Riboside,NSC-4911,Ribosyl-6-mercaptopurine,6 Mercaptopurine Riboside,Riboside, 6-Mercaptopurine,Ribosyl 6 mercaptopurine
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A R Paterson, and L R Babb, and J H Paran, and C E Cass
March 1977, Experimental cell research,
A R Paterson, and L R Babb, and J H Paran, and C E Cass
November 1977, Molecular pharmacology,
A R Paterson, and L R Babb, and J H Paran, and C E Cass
August 1983, The Journal of pharmacy and pharmacology,
A R Paterson, and L R Babb, and J H Paran, and C E Cass
January 1978, Biochemical pharmacology,
A R Paterson, and L R Babb, and J H Paran, and C E Cass
November 1984, Biochemical pharmacology,
A R Paterson, and L R Babb, and J H Paran, and C E Cass
December 1987, Brain research,
A R Paterson, and L R Babb, and J H Paran, and C E Cass
November 1985, Biochemical pharmacology,
A R Paterson, and L R Babb, and J H Paran, and C E Cass
November 1987, The Journal of general virology,
A R Paterson, and L R Babb, and J H Paran, and C E Cass
September 1977, Molecular pharmacology,
Copied contents to your clipboard!